Finance

Beta
Lists
SDGR:NASDAQ
Schrodinger Inc
$14.40
+0.14%
(+0.020) 1D
$14.31
-0.62% (-0.090)
After hours
Closed: Jun 8, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SDGR...
Open
$14.52
High
$14.73
Low
$14.28
Mkt. cap
1.08B
Avg. vol.
1.47M
Volume
866.30K
52-wk high
$27.63
52-wk low
$10.95
EPS
-$1.40
Beta
1.65
Shares outstanding
65.56M
No. of employees
850
Open
$14.52
High
$14.73
Low
$14.28
Mkt. cap
1.08B
Avg. vol.
1.47M
Volume
866.30K
52-wk high
$27.63
52-wk low
$10.95
EPS
-$1.40
Beta
1.65
Shares outstanding
65.56M
No. of employees
850
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to SDGR in the past 3 months
Buy
Buy
5
Hold
2
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for SDGR in the last 3 months.
Highest
Current $14.40
$24.00 (+66.67%)
Average
$18.80 (+30.56%)
Lowest
$13.00 (-9.72%)
News stories
From sources across the web
Profile
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science. Schrödinger's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market. Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery. Wikipedia
About Schrodinger Inc
CEORamy Farid
Employees850
Founded1990
Headquarters-
SectorHealth care
Websiteschrodinger.com
Last report
May 5, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.62 / -$0.57
-8.95%miss
Revenue / Est. (USD)
58.59M / 45.67M
+28.29%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
54.76M
54.32M
87.24M
58.59M
Cost of goods sold
28.60M
26.28M
29.94M
29.04M
Cost of revenue
28.60M
26.28M
29.94M
29.04M
Research and development expenses
43.14M
42.76M
41.40M
43.82M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.92M
31.23M
33.05M
34.52M
Operating expense
79.06M
73.99M
74.45M
78.34M
Total operating expenses
107.66M
100.27M
104.39M
107.38M
Operating income
-52.90M
-45.95M
-17.16M
-48.79M
Other non operating income
5.44M
3.62M
3.13M
2.66M
EBT including unusual items
-42.89M
-32.63M
32.97M
-59.62M
EBT excluding unusual items
-47.46M
-42.32M
-14.03M
-46.13M
Income tax expense
287.00K
162.00K
462.00K
408.00K
Effective tax rate
-0.67%
-0.50%
1.40%
-0.68%
Other operating expenses
-
-
-
-
Net income
-43.17M
-32.80M
32.51M
-60.03M
Net profit margin
-78.84%
-60.37%
37.27%
-102.46%
Earnings per share
-0.65
-0.57
-0.18
-0.62
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-51.37M
-44.48M
-15.72M
-47.32M
Gain or loss from assets sale
20.00K
-
-
11.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer